Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Trichoscopy helps effectively tell apart different types of patchy hair loss in Egyptian patients.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.

Oral minoxidil improved male baldness, but had side effects; certain antibiotics effectively treated a rare scalp condition; hair transplants might trigger another scalp condition.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Serotonin's role in mental health is complex and not fully understood, affecting treatment effectiveness.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Exosome-based therapies in dermatology show promise but face challenges in standardization, regulation, and safety.

Choose FDA-cleared red light therapy devices and follow guidelines for safe use.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

Minoxidil is strongly linked to heart problems, and machine learning can improve drug safety checks.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

A rare skin reaction occurred when a man took paracetamol, causing a new rash in an area already affected by hair loss.

Accurate prediction of eye, hair, and skin color in Latin American populations requires region-specific models and ethical guidelines.

Low-dose oral minoxidil may be a promising alternative to topical minoxidil for hair loss.

Effective alopecia treatments exist, but high costs and limited access remain challenges.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Minoxidil can temporarily increase hair shedding, causing anxiety and treatment discontinuation.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

New treatments are needed for non-scarring alopecia due to current limitations.

Start with minoxidil and finasteride for male hair loss; other options exist if needed.

Interest in JAK inhibitors for hair loss increased significantly after media coverage and FDA approval.

Oral minoxidil is an effective alternative for hair loss but may cause more unwanted hair growth.